152 related articles for article (PubMed ID: 9178930)
1. Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM).
Shimura T; Miura T; Usami M; Ishihara E; Tanigawa K; Ishida H; Seino Y
Biol Pharm Bull; 1997 May; 20(5):507-10. PubMed ID: 9178930
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemic activity of to-kai-san (Chinese medicines) in normal and KK-Ay mice.
Miura T; Noda M; Fukunaga T; Furuta K
J Nutr Sci Vitaminol (Tokyo); 1997 Feb; 43(1):11-7. PubMed ID: 9151237
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice.
Miura T; Usami M; Tsuura Y; Ishida H; Seino Y
Biol Pharm Bull; 1995 Nov; 18(11):1623-5. PubMed ID: 8593495
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic effects of globin digest and its active ingredient Leu-Ser-Glu-Leu in ICR mice, streptozotocin-induced diabetic mice and KK-Ay mice.
Nakaoka F; Sasakawa Y; Yamamoto K; Nakao M; Nakamura M; Tong C; Fukuhama C; Kagawa K
Life Sci; 2010 Mar; 86(11-12):424-34. PubMed ID: 20109472
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice.
Miura T; Nosaka K; Ishii H; Ishida T
Biol Pharm Bull; 2005 Nov; 28(11):2152-4. PubMed ID: 16272709
[TBL] [Abstract][Full Text] [Related]
7. Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals.
Ishikawa Y; Saito MN; Ikemoto T; Takeno H; Watanabe K; Tani T
Diabetes Res Clin Pract; 1998 Aug; 41(2):101-11. PubMed ID: 9789716
[TBL] [Abstract][Full Text] [Related]
8. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
[TBL] [Abstract][Full Text] [Related]
9. Colonic delivery of docosahexaenoic acid improves impaired glucose tolerance via GLP-1 secretion and suppresses pancreatic islet hyperplasia in diabetic KK-A(y) mice.
Shida T; Kamei N; Takeda-Morishita M; Isowa K; Takayama K
Int J Pharm; 2013 Jun; 450(1-2):63-9. PubMed ID: 23618969
[TBL] [Abstract][Full Text] [Related]
10. Maslinic acid reduces blood glucose in KK-Ay mice.
Liu J; Sun H; Duan W; Mu D; Zhang L
Biol Pharm Bull; 2007 Nov; 30(11):2075-8. PubMed ID: 17978478
[TBL] [Abstract][Full Text] [Related]
11. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic effect of nitobegiku in KK-Ay diabetic mice.
Miura T; Furuta K; Yasuda A; Iwamoto N; Kato M; Ishihara E; Ishida T; Tanigawa K
Am J Chin Med; 2002; 30(1):81-6. PubMed ID: 12067100
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice.
Miura T; Ueda N; Yamada K; Fukushima M; Ishida T; Kaneko T; Matsuyama F; Seino Y
Biol Pharm Bull; 2006 Mar; 29(3):585-7. PubMed ID: 16508174
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice].
Yang CY; Xie ZG; Cheng WB; Jiang X; Chen ZH
Zhong Yao Cai; 2009 Oct; 32(10):1571-6. PubMed ID: 20112724
[TBL] [Abstract][Full Text] [Related]
15. The difference in hypoglycemic action between polygonati rhizoma and polygonati officinalis rhizoma.
Miura T; Kato A
Biol Pharm Bull; 1995 Nov; 18(11):1605-6. PubMed ID: 8593489
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic effect of the rhizomes of Smilax glabra in normal and diabetic mice.
Fukunaga T; Miura T; Furuta K; Kato A
Biol Pharm Bull; 1997 Jan; 20(1):44-6. PubMed ID: 9013805
[TBL] [Abstract][Full Text] [Related]
17. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
Freund P; Wolff HP; Kühnle HF
Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
[TBL] [Abstract][Full Text] [Related]
18. Determination of hemoglobin A1C in normal and diabetic mice: neonatal streptozotocin-induced diabetic mice and KK-Ay mice.
Kitazawa N; Miura T; Kako M; Usami M; Tanigawa K; Ishida H; Seino Y
Biol Pharm Bull; 1996 Aug; 19(8):1078-9. PubMed ID: 8874820
[TBL] [Abstract][Full Text] [Related]
19. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
20. Improvement of glucose tolerance with immunomodulators on type 2 diabetic animals.
Zhu XP; Satoh J; Muto G; Muto Y; Sagara M; Takahashi K; Seino H; Hirai S; Masuda T; Tanaka S; Ishida H; Seino Y; Toyota T
Biotherapy; 1996; 9(4):189-97. PubMed ID: 9012538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
